|Grant Affiliation:||Weiss: Protection by Neutralizing Antibodies|
|Strategy:||Protein & peptide vaccines|
|Study Type:||Pre-Clinical Non-NHP|
|Study Start Date:||2011-04-12|
|Study Made Public:||2011-08-08|
Further investigation of the neutralising antibodies elicited by modifications to the gp41 membrane proximal region of HIV env.
CAVD 313 is a preclinical rabbit study to further investigate the neutralizing antibodies elicited by modifications to the gp41 membrane proximal region of HIV env.
Sign in to see full information about this study and to download study data.